Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2023-09-21
Summary
This is an observational study compares the positivity rates of two tests for screening for primary aldosteronism: plasma aldosterone renin ratio and 24-hour urine aldosterone in patients with young-onset hypertension with or without other clinical features of primary aldosteronism.
Conditions
- Hypertension
- Primary Aldosteronism
- Urine Aldosterone
Sponsors & Collaborators
-
Dr Ian B Wilkinson
lead OTHER
Principal Investigators
-
Ian Wilkinson, DM, MRCP · University of Cambridge
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-15
- Primary Completion
- 2024-09-30
- Completion
- 2024-12-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Prospective Phenotyping of Autonomous Aldosterone Secretion
NCT03484130 ·Status: ACTIVE_NOT_RECRUITING
-
RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough
NCT01805362 ·Status: COMPLETED ·Phase: NA
-
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
NCT06750172 ·Status: RECRUITING
-
New Screening and Diagnostic Cut-off Points of PA Patients
NCT06571084 ·Status: RECRUITING
-
The Plasma Metabolomics Profiling of Primary Aldosteronism
NCT06500000 ·Status: COMPLETED
-
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
NCT04409431 ·Status: RECRUITING ·Phase: NA
-
Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men
NCT00700583 ·Status: COMPLETED ·Phase: NA
-
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
NCT01728493 ·Status: COMPLETED
-
Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary Hyperaldosteronism
NCT05640128 ·Status: UNKNOWN ·Phase: NA
-
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
NCT05757076 ·Status: COMPLETED
-
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
NCT00865501 ·Status: COMPLETED ·Phase: PHASE3
-
Aldosterone in Diabetic Nephropathy
NCT00870402 ·Status: UNKNOWN ·Phase: PHASE4
-
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
NCT00403910 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
NCT03174847 ·Status: COMPLETED
-
Cardiovascular Evaluation of Adult PHA 1 Patients
NCT00646828 ·Status: COMPLETED
-
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
NCT07137364 ·Status: RECRUITING
-
Steroids-Based Screening for Primary Aldosteronism
NCT06941116 ·Status: RECRUITING
-
Inhibition of Aldosterone in Patients With Chronic Renal Disease
NCT00430924 ·Status: COMPLETED ·Phase: PHASE4
-
Adrenal Artery Ablation Treats Primary Aldosteronism
NCT03398785 ·Status: COMPLETED ·Phase: PHASE3
-
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
NCT00240656 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism
NCT03500120 ·Status: COMPLETED
-
REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study
NCT06108427 ·Status: RECRUITING ·Phase: NA
-
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
NCT04761354 ·Status: COMPLETED
-
Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
NCT01614860 ·Status: COMPLETED
-
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
NCT01848639 ·Status: COMPLETED ·Phase: PHASE3